A detailed history of Lpl Financial LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 11,384 shares of HRMY stock, worth $387,397. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,384
Previous 13,437 15.28%
Holding current value
$387,397
Previous $424,000 26.18%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

SELL
$26.76 - $38.05 $54,938 - $78,116
-2,053 Reduced 15.28%
11,384 $313,000
Q2 2025

Aug 12, 2025

BUY
$27.94 - $35.91 $141,488 - $181,848
5,064 Added 60.48%
13,437 $424,000
Q1 2025

May 07, 2025

BUY
$32.18 - $40.46 $269,443 - $338,771
8,373 New
8,373 $277,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.01B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.